Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001522780-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 19, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
65,067
Total Value
$402,528.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 26,250 | $0.00 | $0.00 | 137,124 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 11,930 | $32.01 | $381,845.90 | 125,194 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 637 | $32.47 | $20,682.18 | 124,557 | Direct | โ | View Details | |
Director | Performance Stock Units | Derivative | Aug 14, 2026 | Exercise/Conversion | 26,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details |